Luminex Corporation was awarded a firm fixed price Blanket Purchase Agreement (BPA) call against its GSA Schedule contract for the provision of polymerase chain reaction (PCR) testing services in support of the Department of Veterans Affairs (VA) Pittsburgh Healthcare System. This single award contract, valued at $532,771.70, has a period of performance through June 30, 2024 and was issued on July 1, 2023 without any set-aside designations.
As the prime contractor, Luminex will leverage its proprietary multiplex diagnostic solutions and immunology technologies to support the clinical testing programs at the VA medical center located in Pittsburgh, Pennsylvania. This BPA call is issued under Luminex's GSA Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits, streamlining procurement of the company's specialized platforms, assays, and testing products through established government contracting vehicles. The scope and purpose of this contract is to provide the VA Pittsburgh Healthcare System with the necessary PCR testing capabilities and related diagnostic services to support its healthcare operations and patient care initiatives.
Generated 4/11/24, 9:08 AM